Innovac Therapeutics
Innovac Therapeutics is a biotechnology company dedicated to developing innovative vaccines for patients with unmet medical needs, using proprietary RNA technology platforms and manufacturing capabilities. Their mission is to harness the power of mRNA technology to develop therapies for unmet needs, focusing on infectious diseases and cancer. The company is building a leading mRNA-LNP platform to generate first-in-class and best-in-class clinical candidates, aiming to shorten timelines from concept to clinic and address substantial medical needs.
Industries
Nr. of Employees
small (1-50)
Innovac Therapeutics
Products
mRNA design platform (computational)
Software-driven mRNA design tools implementing codon optimization, secondary-structure and 5'/3' UTR optimization to improve mRNA translation and stability.
Computational epitope design package
A computational package for designing T-cell epitope vaccines and selecting universal T-cell epitopes to elicit CD8+ and CD4+ responses.
LNP delivery system
Lipid nanoparticle formulations designed to encapsulate mRNA, protect it from degradation, and enable cellular delivery.
mRNA design platform (computational)
Software-driven mRNA design tools implementing codon optimization, secondary-structure and 5'/3' UTR optimization to improve mRNA translation and stability.
Computational epitope design package
A computational package for designing T-cell epitope vaccines and selecting universal T-cell epitopes to elicit CD8+ and CD4+ responses.
LNP delivery system
Lipid nanoparticle formulations designed to encapsulate mRNA, protect it from degradation, and enable cellular delivery.
Services
End-to-end mRNA-LNP manufacturing
Manufacturing services covering plasmid production, in vitro transcription, mRNA purification, LNP formulation, fill/finish, and packaging for mRNA-LNP products.
Computational design services for mRNA sequences and epitopes
Computational design and algorithmic services for codon and UTR optimization, secondary-structure-informed mRNA design, and T-cell epitope/neoantigen selection.
Analytical and immunology assay services
Execution and development of cellular immunology assays including flow cytometry, ELISA/ELISPOT, antigen-specific T and B cell assays, and multi-cytokine analysis to support preclinical programs.
End-to-end mRNA-LNP manufacturing
Manufacturing services covering plasmid production, in vitro transcription, mRNA purification, LNP formulation, fill/finish, and packaging for mRNA-LNP products.
Computational design services for mRNA sequences and epitopes
Computational design and algorithmic services for codon and UTR optimization, secondary-structure-informed mRNA design, and T-cell epitope/neoantigen selection.
Analytical and immunology assay services
Execution and development of cellular immunology assays including flow cytometry, ELISA/ELISPOT, antigen-specific T and B cell assays, and multi-cytokine analysis to support preclinical programs.
Expertise Areas
- mRNA vaccine design and development
- LNP formulation and delivery systems
- Computational immunology and epitope design
- CMC and process development for biologics
Key Technologies
- mRNA sequence optimization
- Lipid nanoparticle (LNP) delivery
- Epitope prediction / neoantigen selection algorithms
- Next-generation sequencing (NGS) workflows